Sera Prognostics

📍 Salt Lake City, United States🗓 Founded 2008👥 73 employees💰 Last funded Apr 2021
Biotechnology Research🌐 seraprognostics.com
Website LinkedIn
Sera Prognostics is a leading proteomic and bioinformatics company dedicated to improving the lives of women and babies through precision biomarker-based tests designed to enhance pregnancy care. Our vision is to deliver pivotal information to physicians early in pregnancy to help them to improve the health of their patients and reduce costs of healthcare delivery. The PreTRM® Test reports to a physician the individualized risk of premature birth, enabling earlier proactive interventions in patients with higher risk. Were also developing a robust pipeline of innovative tests focused on other complications of pregnancy, including preeclampsia, gestational diabetes, growth restriction, and others. Learn more about our values, culture, and open positions on our website.
5
Total investors
0
Early stage
0
Mid stage
3
Late stage
2008
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
4
France
1
Investor activity2015–2021 · investors recorded per year
20152201812020120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sera Prognostics?
Sera Prognostics has 5 investors on record on gritt.io and 3 late-stage investors.
When did Sera Prognostics last raise funding?
The most recent investment in Sera Prognostics recorded on gritt.io was in April 2021.
When was Sera Prognostics founded?
Sera Prognostics was founded in 2008.
What industry is Sera Prognostics in?
Sera Prognostics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sera Prognostics based?
Sera Prognostics is headquartered in Salt Lake City, United States.